Gareth Brady

2.5k total citations · 1 hit paper
32 papers, 1.9k citations indexed

About

Gareth Brady is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Gareth Brady has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Gareth Brady's work include interferon and immune responses (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Herpesvirus Infections and Treatments (6 papers). Gareth Brady is often cited by papers focused on interferon and immune responses (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Herpesvirus Infections and Treatments (6 papers). Gareth Brady collaborates with scholars based in Ireland, United Kingdom and Germany. Gareth Brady's co-authors include Andrew Bowie, Paul J. Farrell, Luke O'neill, Caroline A. Jefferies, Katherine A. Fitzgerald, Georgina J MacArthur, Mary T. Harte, Aisling Dunne, Eva M. Pålsson‐McDermott and Dirk E. Smith and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gareth Brady

30 papers receiving 1.9k citations

Hit Papers

Mal (MyD88-adapter-like) is required for Toll-like recept... 2001 2026 2009 2017 2001 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gareth Brady Ireland 17 1.2k 474 373 359 336 32 1.9k
Pearl Gray United States 13 1.9k 1.5× 552 1.2× 474 1.3× 356 1.0× 433 1.3× 14 2.4k
Elizabeth E. M. Bates France 24 2.1k 1.7× 727 1.5× 262 0.7× 329 0.9× 562 1.7× 28 2.9k
Naoya Shimada Japan 5 1.8k 1.4× 462 1.0× 271 0.7× 356 1.0× 441 1.3× 8 2.3k
Baidong Hou China 26 1.9k 1.5× 788 1.7× 205 0.5× 291 0.8× 517 1.5× 59 3.0k
Marianne Quiding‐Järbrink Sweden 31 2.1k 1.6× 442 0.9× 121 0.3× 535 1.5× 309 0.9× 74 3.2k
Ang Lin China 23 948 0.8× 842 1.8× 175 0.5× 252 0.7× 297 0.9× 48 2.0k
Sean E. Doyle United States 18 2.4k 1.9× 721 1.5× 491 1.3× 624 1.7× 760 2.3× 20 3.5k
Mei Gong United States 14 2.0k 1.6× 897 1.9× 248 0.7× 327 0.9× 285 0.8× 16 2.6k
Anne M. Stevens United States 18 1.3k 1.1× 397 0.8× 189 0.5× 332 0.9× 352 1.0× 26 2.1k

Countries citing papers authored by Gareth Brady

Since Specialization
Citations

This map shows the geographic impact of Gareth Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Brady more than expected).

Fields of papers citing papers by Gareth Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gareth Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Brady. The network helps show where Gareth Brady may publish in the future.

Co-authorship network of co-authors of Gareth Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Gareth Brady. A scholar is included among the top collaborators of Gareth Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gareth Brady. Gareth Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haas, Darya A., et al.. (2024). Molluscum contagiosum virus protein MC089 inhibits interferon regulatory factor 3 activation. Journal of General Virology. 105(8). 1 indexed citations
2.
Townsend, Liam, Jean Dunne, William McCormack, et al.. (2024). Immune response in vaccinated healthcare workers with frequent COVID-19 infections is characterised by blunted IFNγ and IL-2 responses to SARS-CoV-2 variants. Clinical Immunology. 268. 110371–110371. 1 indexed citations
4.
Ghanim, Murad, John Guardiola, Gareth Brady, et al.. (2023). P-070 SARS-CoV2 antibody isotypes in seminal fluid of vaccinated men. Human Reproduction. 38(Supplement_1).
5.
Brady, Gareth, William McCormack, Adam H. Dyer, et al.. (2023). Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis. Clinical & Experimental Immunology. 215(2). 177–189.
6.
Phelan, Thomas, Clara Lawler, Andreas Pichlmair, et al.. (2023). Molluscum Contagiosum Virus Protein MC008 Targets NF-κB Activation by Inhibiting Ubiquitination of NEMO. Journal of Virology. 97(3). e0010823–e0010823. 2 indexed citations
7.
Domegan, Lisa, Cathal Walsh, Peadar Rooney, et al.. (2023). SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations. Frontiers in Medicine. 10. 1078022–1078022. 5 indexed citations
8.
Batten, Isabella, et al.. (2023). Optimal LC-MS metabolomic profiling reveals emergent changes to monocyte metabolism in response to lipopolysaccharide. Frontiers in Immunology. 14. 1116760–1116760. 2 indexed citations
9.
Gu, Lili, Gareth Brady, Susan Carpenter, et al.. (2022). Myeloid cell nuclear differentiation antigen controls the pathogen-stimulated type I interferon cascade in human monocytes by transcriptional regulation of IRF7. Nature Communications. 13(1). 14–14. 33 indexed citations
10.
Brady, Gareth, et al.. (2022). Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation. Biochemical Pharmacology. 205. 115246–115246. 31 indexed citations
11.
Phelan, Thomas, Jean Dunne, Niall Conlon, et al.. (2021). Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity. Viruses. 13(7). 1371–1371. 11 indexed citations
12.
Brady, Gareth, et al.. (2020). Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism. Lara D. Veeken. 59(Supplement_3). iii33–iii41. 11 indexed citations
13.
Phelan, Thomas, Mark A. Little, & Gareth Brady. (2020). Targeting of the cGAS-STING system by DNA viruses. Biochemical Pharmacology. 174. 113831–113831. 32 indexed citations
14.
Coughlan, Alice M., Joana Cabral, Barry Moran, et al.. (2019). Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies. Frontiers in Immunology. 10. 2603–2603. 50 indexed citations
15.
Dooley, Dearbhaile, Mirjan M. van Timmeren, Vincent O’Reilly, et al.. (2018). Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis. Kidney International. 94(5). 926–936. 3 indexed citations
16.
Brady, Gareth, Hannah J. Whiteman, Lindsay C. Spender, & Paul J. Farrell. (2009). Downregulation of RUNX1 by RUNX3 Requires the RUNX3 VWRPY Sequence and Is Essential for Epstein-Barr Virus-Driven B-Cell Proliferation. Journal of Virology. 83(13). 6909–6916. 38 indexed citations
17.
Brady, Gareth & Paul J. Farrell. (2009). RUNX3‐mediated repression of RUNX1 in B cells. Journal of Cellular Physiology. 221(2). 283–287. 16 indexed citations
18.
Lucchesi, Walter, Gareth Brady, Oliver Dittrich‐Breiholz, et al.. (2008). Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2. Journal of Virology. 82(15). 7456–7466. 54 indexed citations
19.
Brady, Gareth, et al.. (2005). Schlafen-1 Causes a Cell Cycle Arrest by Inhibiting Induction of Cyclin D1. Journal of Biological Chemistry. 280(35). 30723–30734. 64 indexed citations
20.
Fitzgerald, Katherine A., Eva M. Pålsson‐McDermott, Andrew Bowie, et al.. (2001). Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413(6851). 78–83. 1006 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026